Unconfigured Ad
Collapse
Any topic/question that does not fit into the subcategories below. If you're unsure of where to put something, ask in here!
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by nilshomer, 05-08-2010, 02:19 PM
|
52 responses
118,516 views
0 reactions
|
Last Post
by archana87
04-23-2019, 01:18 PM
|
||
|
Started by njt638, 08-21-2011, 04:03 AM
|
1 response
1,675 views
0 reactions
|
Last Post
by samanta
08-24-2011, 11:56 AM
|
||
|
Started by ardmore, 07-18-2011, 06:50 AM
|
12 responses
3,526 views
0 reactions
|
Last Post
by ardmore
08-24-2011, 09:10 AM
|
||
|
Started by yhong, 08-22-2011, 04:57 PM
|
1 response
2,210 views
0 reactions
|
Last Post
by nilshomer
08-24-2011, 09:10 AM
|
||
|
Started by ijivanjee, 08-19-2011, 05:09 AM
|
2 responses
2,198 views
0 reactions
|
Last Post
by ijivanjee
08-24-2011, 05:42 AM
|
||
|
Started by attilav, 08-18-2011, 04:07 AM
|
2 responses
2,614 views
0 reactions
|
Last Post
by scordes
08-22-2011, 12:59 PM
|
||
|
Started by whitestein, 08-17-2011, 08:22 AM
|
2 responses
2,603 views
0 reactions
|
Last Post
by whitestein
08-19-2011, 05:36 AM
|
||
|
Started by schmima, 08-18-2011, 02:30 AM
|
2 responses
3,597 views
0 reactions
|
Last Post
by schmima
08-18-2011, 04:03 AM
|
||
|
Started by bbrij87, 08-03-2011, 01:45 PM
|
11 responses
5,966 views
0 reactions
|
Last Post
by Bioderek
08-18-2011, 02:23 AM
|
||
|
Started by joscarhuguet, 08-17-2011, 11:11 AM
|
0 responses
3,070 views
0 reactions
|
Last Post
by joscarhuguet
08-17-2011, 11:11 AM
|
||
|
Started by marcowanger, 08-14-2011, 06:13 PM
|
0 responses
6,936 views
0 reactions
|
Last Post
by marcowanger
08-14-2011, 06:13 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
widgetinstance 229 (<!-- ##phrase_widget_229_searchTitle_0## -->) skipped due to lack of content & hide_module_if_empty option.
Recent Articles
Collapse
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 09:51 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:51 AM
|
||
|
Started by SEQadmin2, 09-25-2026, 09:06 AM
|
0 responses
34 views
0 reactions
|
Last Post
by SEQadmin2
09-25-2026, 09:06 AM
|
||
|
Started by SEQadmin2, 09-23-2026, 11:05 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
09-23-2026, 11:05 AM
|